| Stage | TMO | % of rev | MIR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $12.1B | 100.00% | $278M | 100.00% | TMO ×43.69 |
| Gross profit | $5.1B | 42.28% | $132M | 47.34% | MIR +5.1pp |
| Operating income | $2.3B | 18.65% | $17M | 6.19% | TMO +12.5pp |
| Pre-tax income | $2.1B | 17.20% | $11M | 3.92% | TMO +13.3pp |
| Net income | $1.7B | 14.23% | $8M | 2.81% | TMO +11.4pp |
| Stage | TMO | MIR | Gap · A − B |
|---|---|---|---|
| Revenue | $12.1B100.00% | $278M100.00% | TMO ×43.69 |
| Gross profit | 42.28%$5.1B | 47.34%$132M | MIR +5.1pp |
| Operating income | 18.65%$2.3B | 6.19%$17M | TMO +12.5pp |
| Pre-tax income | 17.20%$2.1B | 3.92%$11M | TMO +13.3pp |
| Net income |
| 14.23%$1.7B |
| 2.81%$8M |
| TMO +11.4pp |
No disclosed counterparties: MIR.
None